Quantcast
Free Trial!
Today’s Best Stocks To Trade!  Click Here


ABMD

ABIOMED CLOSES OFFERING OF 2.42M SHARES AT $17.38 EACH - 08/22 - 11:55 AM ET

Abiomed Climbs On Increased Volume - 08/19 - 09:32 AM ET

ABIOMED TO OFFER 2.42M SHARES TO THE PUBLIC - 08/18 - 04:10 PM ET

ABIOMED Reaffirms - 08/07 - 07:49 AM ET

ABMD: Q1 Earnings Call @ 08:30 ET Today [delayed] - 08/07 - 07:43 AM ET

Abiomed Announces 16% Revenue Growth to $16.4 Million for First Quarter of Fiscal 2009 - 08/07 - 07:00 AM ET

ABMD touches 50-day moving average at 18.93 - 08/05 - 01:19 AM ET

Abiomed First Fiscal Quarter 2009 Earnings and Conference Call Notification - 07/31 - 10:10 AM ET

Abiomed Announces Impella 2.5 Capacity Expansion Plans in Ireland - 07/30 - 07:00 AM ET

Abiomed Closes At Multi-Year High - 06/16 - 04:23 PM ET

Abiomed Hits New High In Early Trading - 06/16 - 09:40 AM ET

Abiomed Sets Multi-Year High On FDA Approval - 06/03 - 07:53 AM ET

FDA Approves Abiomed's Impella 2.5 To Maintain Blood Flow In Heart Failure Patients - 06/03 - 12:09 AM ET

Abiomed Hits Highest Level In Over Three Years On FDA Approval - 06/02 - 04:49 PM ET

ABIOMED JUMPS 15%; GETS FDA OK FOR IMPELLA 2.5 CARDIAC ASSIST DEVICE - 06/02 - 10:28 AM ET

Abiomed Hits Multi-Year High - 06/02 - 09:41 AM ET

ABMD: Receives 510(k) Clearance from FDA for Impella 2.5 Device - 06/02 - 08:43 AM ET

ABMD: Conference call regarding to discuss the clearance of the Impella 2.5 cardiac assist device @ 08:30 ET Today [delayed] - 06/02 - 07:41 AM ET

ABIOMED GETS FDA 510(K) CLEARANCE FOR IMPELLA 2.5 DEVICE - 06/02 - 07:02 AM ET

Abiomed Inc (ABMD) Corporate Event Announcement Notice - 05/22 - 08:40 PM ET

Page 1 of 7     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index

 

Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.